论文部分内容阅读
目的观察甲氰咪胍联合思密达治疗小儿病毒性腹泻的有效性与安全性。方法58例小儿病毒性腹泻被随机分成两组,治疗组30例应用甲氰咪胍联合思密达治疗,对照组28例应用病毒唑治疗。结果治疗组总有效率93.3%,对照组总有效率71.4%,两组差异有统计学意义(P<0.05),在止泻时间和总疗程治疗组短于对照组,两者差异有统计学意义(P<0.05)。治疗组未见明显不良反应。结论甲氰咪胍联合思密达治疗小儿病毒性腹泻临床疗效确切,无明显不良反应,方法简便,价廉易得,易于接受,适于推广。
Objective To observe the efficacy and safety of cimetidine combined with Smecta in the treatment of viral diarrhea in children. Methods Fifty-eight pediatric viral diarrhea were randomly divided into two groups. The treatment group was treated with cimetidine combined with Smecta, and the control group with ribavirin. Results The total effective rate was 93.3% in the treatment group and 71.4% in the control group, with significant difference between the two groups (P <0.05). The difference between the two groups was statistically significant Significance (P <0.05). No significant adverse reactions in the treatment group. Conclusions Cimetidine combined with Smecta is effective in treating viral diarrhea in children with no obvious adverse reactions. The method is simple, inexpensive, easy to accept and suitable for promotion.